HOMILADORLIKDA TEMIR TANQISLIGI ANEMIYASINI TASHXISLASH VA DAVOLASH: RETROSPEKTIV KLINIK KUZATUV ASOSIDA TAHLIL

Authors

  • Navruzova Dilshoda Tolibovna Author

Keywords:

Kalit so‘zlar: Homiladorlik, temir tanqisligi anemiyasi, ferric carboxymaltose, tashxis, davolash, gemoglobin, parenteral temir.

Abstract

Annotatsiya.  Temir  tanqisligi  anemiyasi  (TTA)  homiladorlik  davrida  keng 
tarqalgan  gematologik  buzilish  bo‘lib,  ona  va  homila  salomatligiga  salbiy  ta’sir 
ko‘rsatadi. Ushbu tadqiqot homiladorlikning ikkinchi va uchinchi trimestrida Hb < 8 
g/dL bo‘lgan 57 nafar bemorda temir tanqisligini tashxislash mezonlari va davolashda 
og‘iz  orqali  hamda  tomir  ichiga  beriladigan  temir  preparatlarining  samaradorligini 
solishtirishga  qaratilgan.  Tadqiqot  natijalariga  ko‘ra,  ferric  carboxymaltose  (FCM) 
preparatini  tomir  ichiga  yuborish  Hb  va  MCV  darajalarini  sezilarli  darajada 
yaxshilagan.  Yon  ta’sirlar  minimal  bo‘lgan.  FCM  temir  tanqisligi  anemiyasini 
davolashda samarali va xavfsiz vosita sifatida tavsiya etilishi mumkin. 

References

Adabiyotlar:

1. Yau JWY, Lee P, Lee VWH, Lam DSC. Diabetic retinopathy—update on

pathophysiology and treatment. Curr Diabetes Rev. 2010;6(3):166-178.

2. Alam MR, Singh D. Assessment of efficacy of parenteral iron therapy for treatment

of moderate to severe anemia in pregnancy. Int J Health Clin Res. 2021;4(1):1-4.

3. Bhudhrani DS, Godria P. Safety and efficacy of ferric carboxymaltose in

management of iron deficiency anemia in pregnant and peripartum women. Int J

Reprod Contracept Obstet Gynecol. 2024;13(2):123-130.

4. Shah AB, Shah PT, Patel RV, Patel S. Importance of parenteral iron sucrose therapy

in correction of iron deficiency anemia during pregnancy. Int J Reprod Contracept

Obstet Gynecol. 2022;11(5):2045-2050.

5. Natarajan A, Baskaran P. Iron therapy in pregnant women with iron deficiency

anemia: a meta-analysis. Int J Basic Clin Pharmacol. 2021;10(8):890-896.

6. Esin S, Yırcı B, Zengin T, Yalvaç S, Kandemir Ö. Parenteral iron sucrose therapy

for moderate and severe iron-deficiency anemia in pregnancy. Gynecol Obstet

Reprod Med. 2016;22(2):73-77.

7. Sharma A, Sharma D. A randomized controlled trial to compare injection ferric

carboxymaltose and oral iron in treating iron deficiency anemia during pregnancy.

Indian J Obstet Gynecol Res. 2022;9(3):322-327.

8. Zimmermann P, Antonelli MC, Sharma R, Müller A, Zelgert C, Fabre B, et al.

Prenatal stress perturbs fetal iron homeostasis in a sex-specific manner. arXiv.

2021. doi:10.48550/arXiv.2105.12809.

9. Bhandari N, Khaled MA, Singhal S. Oral versus intravenous iron therapy in

pregnant women with iron deficiency anemia: A randomized controlled trial. J

Obstet Gynaecol India. 2019;69(3):221-225.

10. Milman N. Iron therapy in pregnancy—a call for new strategies. Ann Hematol.

2011;90(12):1419-1426.

11. Breymann C. Iron deficiency anemia in pregnancy. Semin Hematol.

2015;52(4):339-347.

12. Milman N, Byg KE, Bergholt T, Eriksen L, Hvas AM. Iron status and iron turnover

during normal pregnancy. Acta Obstet Gynecol Scand. 2007;86(4):416-423.

Published

2025-10-04

How to Cite

Navruzova Dilshoda Tolibovna. (2025). HOMILADORLIKDA TEMIR TANQISLIGI ANEMIYASINI TASHXISLASH VA DAVOLASH: RETROSPEKTIV KLINIK KUZATUV ASOSIDA TAHLIL . Ta’lim Innovatsiyasi Va Integratsiyasi, 54(1), 108-111. https://journalss.org/index.php/tal/article/view/1864